The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent warning about counterfeit Deekins Amoxycillin 500mg capsules, which are suspected of causing severe adverse reactions in consumers.
The agency has identified and recalled batch number 4C639001, which is marked with a manufacturing date of March 2024 and an expiry date of February 2027. NAFDAC is urging the public to remain alert and immediately stop using any products from this batch.
At a press briefing held in Abuja, NAFDAC’s Director-General, Prof. Mojisola Adeyeye, revealed that the issue is being taken very seriously and would be escalated to the World Health Organization’s (WHO) Global Surveillance and Monitoring System. This step is being taken due to concerns that the counterfeit product may have spread beyond Nigeria’s borders.
Prof. Adeyeye confirmed that NAFDAC has already taken samples of the suspicious batch for laboratory analysis. In addition, the agency has invited key stakeholders, including Quality Control and Production Managers, to provide further insights into the situation. This investigation aims to track the origins of the counterfeit drugs and prevent further public health risks.
“We are closely monitoring the situation, and our analysis is ongoing,” Prof. Adeyeye said. “In the meantime, we have notified the Pharmacy Council of Nigeria, which is responsible for issuing site licenses, and the pharmacist in charge has also been alerted.”
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent warning about counterfeit Deekins Amoxycillin 500mg capsules, which are suspected of causing severe adverse reactions in consumers.
The agency has identified and recalled batch number 4C639001, which is marked with a manufacturing date of March 2024 and an expiry date of February 2027. NAFDAC is urging the public to remain alert and immediately stop using any products from this batch.
At a press briefing held in Abuja, NAFDAC’s Director-General, Prof. Mojisola Adeyeye, revealed that the issue is being taken very seriously and would be escalated to the World Health Organization’s (WHO) Global Surveillance and Monitoring System. This step is being taken due to concerns that the counterfeit product may have spread beyond Nigeria’s borders.
Prof. Adeyeye confirmed that NAFDAC has already taken samples of the suspicious batch for laboratory analysis. In addition, the agency has invited key stakeholders, including Quality Control and Production Managers, to provide further insights into the situation. This investigation aims to track the origins of the counterfeit drugs and prevent further public health risks.
“We are closely monitoring the situation, and our analysis is ongoing,” Prof. Adeyeye said. “In the meantime, we have notified the Pharmacy Council of Nigeria, which is responsible for issuing site licenses, and the pharmacist in charge has also been alerted.”
Kindly follow Ekwutosblog for verified News and Current Affairs in addition to insightful contents that inform, inspire, educate and entertain you always.
